Boglarka Gyurkocza

Boglarka Gyurkocza, M.D. serves as an Academic Associate Professor in the Clinical Research Division at Fred Hutchinson Cancer Center and Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine. She practices at Fred Hutch's South Lake Union Clinic and UW Medical Center - Montlake, specializing in hematology and hematology-oncology with a focus on hematopoietic cell transplantation and immunotherapy.

Dr. Gyurkocza earned her MD from Semmelweis University, completed residency in Internal Medicine at Westchester Medical Center (New York Medical College), and fellowship in Hematology-Oncology at UMass Chan Medical School. She holds board certification in Internal Medicine (2003-2013), Hematology (2007-present), and Medical Oncology (2008-2018) from the American Board of Internal Medicine.

Her research program centers on developing novel treatment approaches for older adults and medically fragile patients requiring hematopoietic cell transplantation. With over 60 publications spanning two decades, her work examines critical areas including microbiome-transplant interactions, GVHD prevention strategies, and innovative cellular therapies. Recent high-impact studies in New England Journal of Medicine and Cell have advanced understanding of how gut microbiota influences transplant outcomes and mortality.

As a clinician-scientist, Dr. Gyurkocza treats a comprehensive range of hematologic malignancies including acute leukemias, lymphomas, myelodysplastic syndromes, and graft-versus-host disease. She emphasizes evidence-based, compassionate care with transparent communication to help patients navigate complex treatment decisions. Her clinical practice integrates participation in multiple institutional clinical trials aimed at improving standards of care for immunocompromised patients.

Dr. Gyurkocza's work with medically vulnerable populations reflects personal motivation stemming from her grandmother's death from lung cancer when she was 13. She values celebrating patient milestones including transplant anniversaries and post-treatment pregnancies, highlighting her holistic approach to cancer care that extends beyond medical interventions to encompass quality of life considerations.